These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28296712)

  • 1. Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma.
    Leon-Ferre RA; Kottschade LA; Block MS; McWilliams RR; Dronca RS; Creagan ET; Allred JB; Lowe VJ; Markovic SN
    Melanoma Res; 2017 Aug; 27(4):335-341. PubMed ID: 28296712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study.
    Madu MF; Timmerman P; Wouters MWJM; van der Hiel B; van der Hage JA; van Akkooi ACJ
    Melanoma Res; 2017 Jun; 27(3):251-257. PubMed ID: 28225434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma
    Koskivuo I; Kemppainen J; Giordano S; Seppänen M; Veräjänkorva E; Vihinen P; Minn H
    Acta Oncol; 2016 Nov; 55(11):1355-1359. PubMed ID: 27553064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
    Reddy JP; Tang C; Shih T; Kim B; Kim C; Nguyen QN; Welsh J; Benveniste M; Zhang J; Liao Z; Gomez DR
    Clin Lung Cancer; 2017 Mar; 18(2):141-148. PubMed ID: 27913215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma.
    Lewin J; Sayers L; Kee D; Walpole I; Sanelli A; Te Marvelde L; Herschtal A; Spillane J; Gyorki D; Speakman D; Estall V; Donahoe S; Pohl M; Pope K; Chua M; Sandhu S; McArthur GA; McCormack CJ; Henderson M; Hicks RJ; Shackleton M
    Ann Oncol; 2018 Jul; 29(7):1569-1574. PubMed ID: 29659679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies.
    Rueth NM; Xing Y; Chiang YJ; Cromwell KD; Ross MI; Lee JE; Gershenwald JE; Royal RE; Cormier JN
    Ann Surg; 2014 Jun; 259(6):1215-22. PubMed ID: 24096759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancer.
    Rosko A; Birkeland A; Shuman A; Prince M; Bradford C; Wolf G; Worden F; Eisbruch A; Srinivasan A; Wong KK; Spector ME
    Head Neck; 2017 May; 39(5):980-987. PubMed ID: 28236331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
    Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
    J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma.
    Dieng M; Lord SJ; Turner RM; Nieweg OE; Menzies AM; Saw RPM; Einstein AJ; Emmett L; Thompson JF; Lo SN; Morton RL
    Ann Surg Oncol; 2022 May; 29(5):2871-2881. PubMed ID: 35142966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of PET/CT in patients with stage I-III melanoma.
    Avilés Izquierdo JA; Molina López I; Sobrini Morillo P; Márquez Rodas I; Mercader Cidoncha E
    Clin Transl Oncol; 2020 Aug; 22(8):1414-1417. PubMed ID: 31873917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
    Abbott RA; Acland KM; Harries M; O'Doherty M
    Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
    Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
    Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB-III melanoma patients.
    Helvind NM; Aros Mardones CA; Hölmich LR; Hendel HW; Bidstrup PE; Sørensen JA; Chakera AH
    Eur J Surg Oncol; 2021 Dec; 47(12):3020-3027. PubMed ID: 34120809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D Melanoma.
    Turner RM; Dieng M; Khanna N; Nguyen M; Zeng J; Nijhuis AAG; Nieweg OE; Einstein AJ; Emmett L; Lord SJ; Menzies AM; Thompson JF; Saw RPM; Morton RL
    Ann Surg Oncol; 2021 Aug; 28(8):4561-4569. PubMed ID: 33393039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of surveillance imaging for resected high-risk melanoma.
    Yan MK; Adler NR; Wolfe R; Pan Y; Chamberlain A; Kelly J; Yap K; Voskoboynik M; Haydon A; Shackleton M; Mar VJ
    Asia Pac J Clin Oncol; 2023 Aug; 19(4):566-573. PubMed ID: 36540019
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Lawal I; Lengana T; Ololade K; Boshomane T; Reyneke F; Modiselle M; Vorster M; Sathekge M
    Nuklearmedizin; 2017 Jun; 56(3):83-89. PubMed ID: 28154879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Advanced Imaging Have a Role in Detecting Local Recurrence of Soft-tissue Sarcoma?
    England P; Hong Z; Rhea L; Hirbe A; McDonald D; Cipriano C
    Clin Orthop Relat Res; 2020 Dec; 478(12):2812-2820. PubMed ID: 32667755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma.
    Nijhuis AAG; Dieng M; Khanna N; Lord SJ; Dalton J; Menzies AM; Turner RM; Allen J; Saw RPM; Nieweg OE; Thompson JF; Morton RL
    Ann Surg Oncol; 2019 Jun; 26(6):1860-1868. PubMed ID: 30911946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography.
    Kim JH; Heo SH; Kim JW; Shin SS; Min JJ; Kwon SY; Jeong YY; Kang HK
    World J Gastroenterol; 2017 Sep; 23(35):6448-6456. PubMed ID: 29085194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.